Chemical inhibitors of 1110008J03Rik can exert their effects through various mechanisms, targeting specific signaling pathways and enzymes that are crucial for the protein's activity. LY294002 and Wortmannin are both inhibitors of PI3K, a lipid kinase involved in multiple cellular processes, including those that can involve 1110008J03Rik. By inhibiting PI3K, these chemicals can disrupt downstream signaling pathways, leading to a decrease in the activity of 1110008J03Rik. Rapamycin directly inhibits mTOR, a central protein in cellular growth and metabolism, which 1110008J03Rik may act downstream of; thus, rapamycin's action can lead to a reduction in the functional activity of 1110008J03Rik. PD98059 and U0126 target MEK, an upstream regulator of ERK, which can be part of the signaling cascade involving 1110008J03Rik. By inhibiting MEK, these chemicals can prevent the activation of downstream components that contribute to the functional state of 1110008J03Rik.
SB203580 targets p38 MAP kinase, which can play a role in stress response pathways that involve 1110008J03Rik, and its inhibition can result in decreased activity of 1110008J03Rik. SP600125 inhibits JNK, another kinase that can be involved in the signaling pathways with 1110008J03Rik, therefore reducing the protein's activity. BAY 11-7082 disrupts NF-κB activation, which can be a part of the signaling network that includes 1110008J03Rik, leading to a reduction in the protein's function. The chemical AG 490 inhibits the JAK/STAT pathway, which may interact with 1110008J03Rik, thereby inhibiting the protein's functional activity. Dasatinib acts on Src family kinases and BCR-ABL, which could be implicated in pathways that 1110008J03Rik is a part of, thus inhibiting its function. Staurosporine, a broad-spectrum kinase inhibitor, can inhibit the activity of kinases in the pathway of 1110008J03Rik, leading to decreased protein activity. Lastly, ZM-447439 inhibits Aurora kinases, which may phosphorylate substrates within the same pathway as 1110008J03Rik, further leading to the inhibition of the protein's function. Through these diverse yet specific mechanisms, each chemical can contribute to the inhibition of 1110008J03Rik by disrupting the protein's role in its respective cellular pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which may be necessary for the signaling pathways involving 1110008J03Rik, leading to functional inhibition of the protein. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially disrupting downstream signaling that could be crucial for 1110008J03Rik activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a kinase which 1110008J03Rik may act downstream of, therefore inhibiting the protein's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream of ERK that could be involved in pathways with 1110008J03Rik, leading to its inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK, potentially preventing activation of pathways that 1110008J03Rik is involved in, inhibiting the protein's function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, which could be involved in signaling pathways of 1110008J03Rik, resulting in its functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may be involved in the same pathways as 1110008J03Rik, leading to inhibition of the protein’s activity. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-κB activation, which could be part of the signaling network involving 1110008J03Rik, inhibiting the protein's function. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $82.00 $323.00 $219.00 $85.00 | 35 | |
Inhibits JAK/STAT pathway, which 1110008J03Rik may be a part of, leading to functional inhibition of the protein. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src family kinases and BCR-ABL, which could be implicated in the pathways involving 1110008J03Rik, inhibiting its function. |